Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |